Sicen Wang

Find an error

Name:
Organization: Key Laboratory of Environment and Genes Related to Diseases
Department: Key Laboratory of Environment and Genes Related to Diseases, Ministry of Education, China School of Medicine
Title:

TOPICS

Co-reporter:Xiaoshuang He;Ping Zhang;Muhammad Saqib;Xiaofang Hou
Analytical Methods (2009-Present) 2017 vol. 9(Issue 33) pp:4828-4836
Publication Date(Web):2017/08/24
DOI:10.1039/C7AY01213F
Breast cancer is one of the most frequent malignant tumors in females. Extracts from Cortex Magnolia Officinalis (CMO) have shown the ability to inhibit the growth of breast cancer cells. In the present study, we developed MCF-7 cell membrane chromatography (CMC) combined with a UHPLC-ESI-MS/MS method to screen and identify the active components from the extract of CMO. Sorafenib and dexamethasone acetate were used as positive and negative control drugs, respectively, to investigate the suitability of this system. Under optimum experimental conditions, two components showed strong retention characteristics on the MCF-7 cell membrane chromatographic column. These compounds were identified as magnolol and honokiol by UHPLC-ESI-MS/MS. Cytotoxicity assay and Hoechst 33258 staining were done to investigate the anti-proliferative activity of the two compounds. The MTT results showed that MCF-7 cell viability decreased gradually in a dose-dependent manner during 48 h. The IC50 of magnolol and honokiol were 85.4 μM and 58.1 μM, respectively. After Hoechst 33258 staining, the cells were observed with bright blue nuclei due to karyopyknosis and chromatin condensation. The screening results showed that both magnolol and honokiol were promising active components of CMO extract having an inhibitory effect on MCF-7 cell growth. This two-dimensional method CMC-UHPLC-ESI-MS/MS could have potential utility for screening target components from traditional Chinese medicines.
Co-reporter:Meng Sun;Yuanyuan Lin;Jie Zhang;Shaohua Zheng
Journal of Separation Science 2016 Volume 39( Issue 5) pp:889-894
Publication Date(Web):
DOI:10.1002/jssc.201501037

A rapid analytical method based on online solid-phase extraction with high-performance liquid chromatography and mass spectrometry has been established and applied to the determination of tannin compounds that may cause adverse effects in traditional Chinese medicine injections. Different solid-phase extraction sorbents have been compared and the elution buffer was optimized. The performance of the method was verified by evaluation of recovery (≥40%), repeatability (RSD ≤ 6%), linearity (r2 ≥ 0.993), and limit of quantification (≤0.35 μg/mL). Five tannin compounds, gallic acid, cianidanol, gallocatechin gallate, ellagic acid, and penta-O-galloylglucose, were identified with concentrations ranging from 3.1–37.4 μg/mL in the analyzed traditional Chinese medicine injections.

Co-reporter:Shengli Han, Chunlei Li, Jing Huang, Fen Wei, Yu Zhang, Sicen Wang
Journal of Chromatography B 2016 Volume 1011() pp:158-162
Publication Date(Web):1 February 2016
DOI:10.1016/j.jchromb.2016.01.001
•New screening method based CMC coupled UHPLC–ESI–MS/MS system was established.•The coupled system can be served as a screening tool for components with α1A–AR activity.•PA, PB, and PC were screened from Peucedanum praeruptorum Dunn by coupled system.•TH, PA, PB, and PC could relax the prostate strips pre-contracted by noradrenaline.Peucedanum praeruptorum Dunn (BaiHuaQianHu in Chinese) is a traditional Chinese medicine that has a long history of use in China. In this study, HEK 293 α1A adrenergic cell membrane chromatography was coupled with UHPLC-ESI-MS/MS and successfully used to identify active components from Peucedanum praeruptorum Dunn. Paeruptorin A, paeruptorin B, and paeruptorin C were identified with α1A adrenergic receptor activity. Pharmacological assays showed that tamsulosin hydrochloride, paeruptorin A, paeruptorin B, and paeruptorin C in concentrations of 1 × 10−8 to 1 × 10−4 mol/mL could relax prostate strips pre-contracted with adrenalin in a concentration dependent manner. Therefore, the HEK293 α1A cell membrane chromatography coupled UHPLC–ESI–MS/MS system may be a potentially useful drug discovery method for screening for medicinal herbal components with α1A adrenergic receptor inhibitory activity.
Co-reporter:Tao Zhang;Yuanyuan Ding;Hongli An;Liuxin Feng
Journal of Separation Science 2015 Volume 38( Issue 18) pp:3247-3253
Publication Date(Web):
DOI:10.1002/jssc.201500488

Tyrosine 367 Cysteine-fibroblast growth factor receptor 4 cell membrane chromatography combined with high-performance liquid chromatography and mass spectrometry was developed. Tyrosine 367 Cysteine-HEK293 cells were used as the cell membrane stationary phase. The specificity and reproducibility of the cell membrane chromatography was evaluated using 1-tert-butyl-3-{2-[4-(diethylamino)butylamino]-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl}urea, nimodipine and dexamethasone acetate. Then, anti-tumor components acting on Tyrosine 367 Cysteine-fibroblast growth factor receptor 4 were screened and identified from extracts of Ligusticum wallichii. Components from the extract were retained on the cell membrane chromatographic column. The retained fraction was directly eluted into high-performance liquid chromatography with mass spectrometry system for separation and identification. Finally, Levistolide A was identified as an active component from Ligusticum wallichii extracts. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide-formazan colorimetric assay revealed that Levistolide A inhibits proliferation of overexpressing the mutated receptor cells with dose-dependent manner. Phosphorylation of fibroblast growth factor receptor 4 was also decrease under Levistolide A treatment. Flex dock simulation verified that Levistolide A could bind with the tyrosine kinase domain of fibroblast growth factor receptor 4. Therefore, Levistolide A screened by the cell membrane chromatography combined with high-performance liquid chromatography and mass spectrometry can arrest cell growth. In conclusion, the two-dimensional high-performance liquid chromatography method can screen and identify potential anti-tumor ingredients that specifically act on the tyrosine kinase domain of the mutated fibroblast growth factor receptor 4.

Co-reporter:Xiaoyu Xie;Fen Wei;Liang Chen
Journal of Separation Science 2015 Volume 38( Issue 6) pp:1046-1052
Publication Date(Web):
DOI:10.1002/jssc.201401142

In this study, highly selective core–shell molecularly imprinted polymers on the surface of magnetic nanoparticles were prepared using protocatechuic acid as the template molecule. The resulting magnetic molecularly imprinted polymers were characterized by transmission electron microscopy, Fourier transform infrared spectroscopy, X-ray diffraction, and vibrating sample magnetometry. The binding performances of the prepared materials were evaluated by static and selective adsorption. The binding isotherms were obtained for protocatechuic acid and fitted by the Langmuir isotherm model and Freundlich isotherm model. Furthermore, the resulting materials were used as the solid-phase extraction materials coupled to high-performance liquid chromatography for the selective extraction and detection of protocatechuic acid from the extracts of Homalomena occulta and Cynomorium songaricum with the recoveries in the range 86.3–102.2%.

Co-reporter:Meng Sun;Xiaofang Hou;Yuanyuan Lin;Jie Zhang
Journal of Separation Science 2015 Volume 38( Issue 18) pp:3145-3150
Publication Date(Web):
DOI:10.1002/jssc.201500362

A high-expression epidermal growth factor receptor cell membrane chromatography using the silica gel with the average particle size of 3 μm as the stationary phase carrier coupled with high-performance liquid chromatography and mass spectrometry was established for the online screening of epidermal growth factor receptor antagonists from Radix Scutellariae (Huang Qin in Chinese), a traditional Chinese medicine. In this study, the growth factor receptor cell membrane chromatography model using the smaller particle size carrier showed a higher efficiency for simultaneous screening baicalein, another one of the potential epidermal growth factor receptor antagonists from Radix Scutellariae extract besides wogonin, which was found in our previous work. The molecular docking result showed the occupancy site and binding mode of baicalein and wogonin with epidermal growth factor receptor tyrosine kinase were similar to gefitinib. The result of the assay for the in vitro inhibitory activity showed that baicalein and wogonin inhibited the growth of the high-expression epidermal growth factor receptor cell in a dose-dependent manner and even achieved a better inhibition effect than gifitinib in the low-dosage range.

Co-reporter:Faqing Ye, Liangfang Chen, Lichuan Hu, Tong Xiao, Shufang Yu, Di Chen, Yu Wang, Guang Liang, Zhiguo Liu, Sicen Wang
Bioorganic & Medicinal Chemistry Letters 2015 Volume 25(Issue 7) pp:1556-1560
Publication Date(Web):1 April 2015
DOI:10.1016/j.bmcl.2015.02.010
Two series of C-8 substituted guanine derivatives were synthesized, one bearing 2-amino substitutions and the other bearing 2-acetamide substitutions. Biological activity tests showed that almost all of them possessed some extent of antitumor activities, and were with lower toxicity against normal human liver HL7702 cells than AZD4547 (the positive control). Among them, N-[8-(4-bromo-1H-indol-3-yl)-6-hydroxy-9H-purin-2-yl]-acetamide exhibited a relatively satisfied inhibition against FGFR1 kinase with IC50 of 1.56 μM and specifically against A549 cells with IC50 of 8.28 μM and B16-F10 cells with IC50 of 6.59 μM. Above all, the introduction of large substituents such as indolyl groups at 8-position of the guanine scaffold probably achieves higher selectivity for FGFR1 as compared with AZD4547.Novel C-8 substituted guanine derivatives were synthesized and evaluated for FGFR1-4 inhibition and anti-cancer activities in vitro.
Co-reporter:Miao Li, Sicen Wang, Langchong He
Journal of Chromatography B 2015 Volume 974() pp:9-16
Publication Date(Web):1 January 2015
DOI:10.1016/j.jchromb.2014.10.019
•VSMC/CMC-MEPS-GC–MS improved the screening method of volatile active compound in complex sample.•VSMC/CMC-MEPS-GC–MS modified the analyte recovery procedure of reported CMC-offline-GC–MS.•CMC and GC–MS reinforce each other under the integration of MEPS. This extends bio-chromatography.Natural products (NPs) are important sources of lead compounds in modern drug discovery. To facilitate the screening of volatile active compounds in NPs, we have developed a new biochromatography method that uses rat vascular smooth muscle cells (VSMC), which are rich in L-type calcium channels (LCC), to prepare the stationary phase. This integrated method, which couples cell membrane chromatography (CMC) with gas chromatography–mass spectrometry (GC–MS) via microextraction by packed sorbent (MEPS) technology, has been termed VSMC/CMC-MEPS-GC–MS. Methodological validation confirmed its specificity, reliability and convenience. Screening results for Radix Angelicae Dahuricae and Fructus Cnidii obtained using VSMC/CMC-MEPS-GC–MS were consistent with those obtained using VSMC/CMC-offline-GC–MS. MEPS connection plays as simplified solid-phase extraction and replaces the uncontrollable evaporation operation in reported offline connections, so our new method is supposed to be more efficient and reliable than the offline ones, especially for compounds that are volatile, thermally unstable or difficult to purify. In application, senkyunolide A and ligustilide were preliminary identified as the volatile active components in Rhizoma Chuanxiong. We have thus confirmed the suitability of VSMC/CMC-MEPS-GC–MS for volatile active compounds screening in NP.
Co-reporter:Shengli Han;Jing Huang;Jingjing Hou
Journal of Separation Science 2014 Volume 37( Issue 13) pp:1525-1532
Publication Date(Web):
DOI:10.1002/jssc.201400236

Radix et Rhizoma Asari is a traditional Chinese medicine, and has many pharmacological effects, such as calming, analgesia, anti-inflammation, antiarrhythmic, antihypertensive, antivirus, etc. But few studies have screened the active compounds from extracts of Radix et Rhizoma Asari for tumor therapy. In this study, a two-dimensional liquid chromatography system was built to screen active compounds acting on epidermal growth factor receptor (EGFR) from Radix et Rhizoma Asari. The screening result showed that asarinin from Radix et Rhizoma Asari was the targeted component that could act on EGFR specificity. The competitive binding assay and molecular docking assay results showed asarinin binding with EGFR in similar manner as with gefitinib, which was used as a positive control drug. Then the antitumor effect of asarinin was studied through cell growth assay in vitro. The results showed that gefitinib and asarinin could inhibit highly expressed EGFR cell growth in a dose-dependent manner in the range of dose from 0.10 to 102.4 μM. This two-dimensional liquid chromatography system will be a useful method in drug discovery from natural medicinal herbs for searching potential antitumor candidates.

Co-reporter:Xiaofang Hou;Xilong Yuan;Bing Zhang;Qinhua Chen
Journal of Separation Science 2013 Volume 36( Issue 4) pp:706-712
Publication Date(Web):
DOI:10.1002/jssc.201200896

Most of the anti-breast cancer drugs are often limited owing to drug resistance and serious adverse reactions. Therefore, development of more targeted and low toxic drugs from traditional Chinese medicines for breast cancer are needed. At the same time, establishment of fast and effective drug screening methods are urgently required. We describe here a 2D LC method of MDA-MB-231 cell membrane chromatography combined with HPLC/MS for recognition, separation, and identification of target components from traditional Chinese medicine Cortex Magnolia officinalis. The MDA-MB-231 cells membrane was used to prepare the chromatographic stationary phase in the first dimension. The active compounds had a retention characteristic on the cell membrane chromatography model (10 × 2.0 mm, 5 μm). The retention fractions were enriched using an online C18 column (10 × 1.0 mm, 5 μm) and were analyzed by the second dimension RP chromatography. Finally, the activity of the retention fractions was tested through in vitro experiments. Results showed that the retention fractions were honokiol and magnolol and the inhibition rate on MDA-MB-231 cell growth were 23 and 64 μM, respectively. These results support the conclusion that this coupled analytical technique could be an efficient method in drug discovery.

Co-reporter:Tao Zhang, Shengli Han, Jing Huang, Sicen Wang
Journal of Chromatography B 2013 Volume 912() pp:85-92
Publication Date(Web):1 January 2013
DOI:10.1016/j.jchromb.2012.10.029
We investigated an analytical method for the recognition separation, and identification of active components from the traditional Chinese medicinal plant Brassica albla L. using fibroblast growth factor receptor 4 cell membrane chromatography (FGFR4/CMC) with high performance liquid chromatography/mass spectrometry (HPLC/MS). HEK293-FGFR4 cells were obtained by stable transfection of the HEK293 cell line with pcDNA3.1 vector containing the FGFR4 gene. Crude extracts of B. albla L. were firstly subjected to FGFR4/CMC column, and the retain contents on the FGFR4/CMC column were then transferred and enriched using a pre-column, and a ten port column switcher were used between FGFR4/CMC column and HPLC. The retained components on FGFR4/CMC column were then directly delivered to the HPLC/MS system for separation and identification. Gefitinib, nicotine, atenolol, and nimodipine were used in order to verify FGFR4/CMC-HPLC/MS system specificity. Subsequently, we investigated the reproducibility and reliability of the FGFR4/CMC-HPLC/MS system. Finally, sinapine was identified as an active component of B. albla L. The MTT colorimetric assay revealed sinapine could inhibit the proliferation of HEK293-FGFR4 cells with dose dependence. Competitive displacement assay approved getitinib could occupy binding site of sinapine with competition way. And FleX dock simulation further exhibited sinapine and gefitinib could bind with the FGFR4 tyrosine active domain. Thus, sinapine is a potential tumor antagonist that acts on the tyrosine kinase domain.Highlights► We built a FGFR4/CMC-online-HPLC/MS system to screening active components from traditional Chinese medicine. ► Sinapine was identified as active compounds in total extracts of Brasscia albla L. ► The binding sites of sinapine and gefitinib was the tyrosine kinase domain of FGFR4 based on competitive displacement assay and FleX dock simulation. ► sinapine could inhibit cell proliferation with dose-dependent.
Co-reporter:Huaizhen He, Shengli Han, Tao Zhang, Jie Zhang, Sicen Wang, Jingjing Hou
Journal of Pharmaceutical and Biomedical Analysis 2012 Volume 62() pp:196-202
Publication Date(Web):25 March 2012
DOI:10.1016/j.jpba.2011.12.025
Radix scutellariae is a traditional Chinese medicine (TCM) and has many pharmacological effects, including antiviral, antibacterial, antifungal, antipyretic, hypotensive, anti-inflammatory and anti-anaphylaxis effects. However, few studies have screened the active compounds in this complex product for tumor therapy. In this study, a two-dimensional online method was developed to screen the active compounds from Radix scutellariae acting on the epidermal growth factor receptor. The screening results showed that wogonin from Radix scutellariae was the targeted component which acted on epidermal growth factor receptor specificity. The in vitro inhibitory activity of wogonin on the viability of cells with high epidermal growth factor receptor expression was tested using the MTT assay. In the dosage range of 0.40–50.0 μM, inhibition of HEK293/EGFR by wogonin was 8.94 ± 0.2, 20.64 ± 5.10, 34.16 ± 5.90 and 69.03 ± 7.80 at the concentrations of 0.4 × 10−6, 2 × 10−6, 10 × 10−6 and 50 × 10−6 mol L−1, respectively. These results showed that wogonin inhibited the growth of cells with high epidermal growth factor receptor expression in a dose-dependent manner.
Co-reporter:Shengli Han, Peng Zhang, Fen Wei and Sicen Wang  
Analytical Methods 2012 vol. 4(Issue 10) pp:3351-3357
Publication Date(Web):02 Aug 2012
DOI:10.1039/C2AY25703C
Agrimony is a traditional Chinese medicine and a herb of Agrimonia pilosa Ledeb belonging to the Rosaceae family. Many pharmacological effects of agrimony have been demonstrated in previous studies. Few studies have screened the active compounds in this complex product for chronic prostatitis. In this study, a two dimensional online method was established. A Sprague-Dawley (SD) rat prostate CMC-online-HPLC/MS method was used to screen, analyze, and identify active compounds acting on α1 adrenergic receptor from agrimony. Via this online method agrimonolide was screened, analyzed, and identified as the active compound acting on α1 adrenergic receptor. Thus, agrimonolide is a potential α1 adrenergic receptor antagonist and requires further study.
Co-reporter:Hui Du, Sicen Wang, Jing Ren, Nan Lv, Langchong He
Journal of Chromatography B 2012 Volumes 887–888() pp:67-72
Publication Date(Web):1 March 2012
DOI:10.1016/j.jchromb.2012.01.011
A new high-expression vascular endothelial growth factor receptor-2 (VEGFR-2) cell membrane chromatography (CMC) method was developed to investigate the affinity of ligands for VEGFR-2. An HEK293 VEGFR-2/CMC system was applied to specifically recognize ligands acting on VEGFR-2. Sorafenib was used as a mobile phase additive to evaluate the effect of the marker's concentration on the retention of sorafenib and taspine, respectively. The relationship among the retention, the types of binding sites and the affinity of taspine binding to VEGFR-2 has also been concerned. The retention behavior indicated that sorafenib had two major binding regions on VEGFR-2, and that taspine might act as a multi-target VEGFR-2 inhibitor with similar biological activity to sorafenib. The equilibrium dissociation constants (KD) obtained from the model are (5.25 ± 0.31) × 10−7 and (9.88 ± 0.54) × 10−5 mol L−1 for sorafenib at the high- and low-affinity sites, respectively, and the corresponding values for taspine are (3.88 ± 0.31) × 10−6 and (7.04 ± 0.49) × 10−5 mol L−1. The two types of binding sites contributed about a 1:2 ratio on the retention of taspine.Highlights► The equilibrium dissociation constants of sorafenib and taspine binding to high- and low-affinity sites on VEGFR-2 were determined, respectively. ► Sorafenib had two major binding regions on VEGFR-2. ► Taspine might act as a multi-target VEGFR-2 inhibitor similar to sorafenib. ► Two types of binding sites contributed a 1:2 ratio on the retention of taspine.
Co-reporter:Hui Du, Jing Ren, Sicen Wang
Food Chemistry 2011 Volume 129(Issue 3) pp:1320-1324
Publication Date(Web):1 December 2011
DOI:10.1016/j.foodchem.2011.05.054
An HPLC-DAD with a short monolithic column method was used for rapid, sensitive and simultaneous determination of liensinine, isoliensinine and neferine in human serum. Chromatographic separation was achieved on an RP-HPLC chromolithic column (50 mm × 4.6 mm i.d.), with a mobile phase of methanol–water–triethylamine–acetic acid (70:30:0.2:0.05), at a flow rate of 1 ml min−1. The calibration curves of three alkaloids exhibit good linear relationship in the concentration range of 0.5–80 μg ml−1. The limits of detection (LODs) of three alkaloids were 20, 20 and 25 ng ml−1, respectively, and the separation time was 4 min. A comparative study has been performed with a normal C18 packed column (150 mm × 4.6 mm i.d., 5 μm). The separation time was 16 min and the LODs of three alkaloids were 56, 56 and 65 ng ml−1, respectively.Highlights► A rapid method for determination of three alkaloids from Lotus Plumule (a kind of tea). ► We have compared the monolithic column and common C18 column. ► The method was validated and used to the determination the compounds in human serum.
Co-reporter:Meng Sun, Jing Ren, Hui Du, Yanmin Zhang, Jie Zhang, Sicen Wang, Langchong He
Journal of Chromatography B 2010 Volume 878(Issue 28) pp:2712-2718
Publication Date(Web):15 October 2010
DOI:10.1016/j.jchromb.2010.08.010
We have developed an online analytical method that combines A431 cell membrane chromatography (A431/CMC) with high performance liquid chromatography and mass spectrometry (LC/MS) for identifying active components from Radix Caulophylli acting on human EGFR. Retention fractions on A431/CMC model were captured onto an enrichment column and the components were directly analyzed by combining a 10-port column switcher with an LC/MS system for separation and preliminary identification. Using Sorafenib tosylate as a positive control, taspine and caulophine from Radix Caulophylli were identified as the active molecules which could act on the EGFR. This A431/CMC-online-LC/MS method can be applied for screening active components acting on EGFR from traditional Chinese medicines exemplified by Radix Caulophylli and will be of great utility in drug discovery using natural medicinal herbs as a source of novel compounds.
Co-reporter:Lan Wang, Jing Ren, Meng Sun, Sicen Wang
Journal of Pharmaceutical and Biomedical Analysis 2010 51(5) pp: 1032-1036
Publication Date(Web):
DOI:10.1016/j.jpba.2009.11.007
Co-reporter:Shengli Han, Peng Zhang, Fen Wei and Sicen Wang
Analytical Methods (2009-Present) 2012 - vol. 4(Issue 10) pp:NaN3357-3357
Publication Date(Web):2012/08/02
DOI:10.1039/C2AY25703C
Agrimony is a traditional Chinese medicine and a herb of Agrimonia pilosa Ledeb belonging to the Rosaceae family. Many pharmacological effects of agrimony have been demonstrated in previous studies. Few studies have screened the active compounds in this complex product for chronic prostatitis. In this study, a two dimensional online method was established. A Sprague-Dawley (SD) rat prostate CMC-online-HPLC/MS method was used to screen, analyze, and identify active compounds acting on α1 adrenergic receptor from agrimony. Via this online method agrimonolide was screened, analyzed, and identified as the active compound acting on α1 adrenergic receptor. Thus, agrimonolide is a potential α1 adrenergic receptor antagonist and requires further study.
N-(3-bromo-5-(trifluoromethyl)phenyl)-4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzamide
Ethyl 4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzoate
Mitogen-activated protein kinase p38
Gelatinase B
Mitogen-activated protein kinase
Benzenamine, 4-[3-(4-morpholinyl)propoxy]-